Consolidated Statements of Operations - USD ($)	3 Months Ended			6 Months Ended
	Apr. 30, 2018	Apr. 30, 2017	[1]	Apr. 30, 2018	Apr. 30, 2017	[1]
Consolidated Statements of Operations
Revenues	$ 3,501,842	$ 3,423,781		$ 7,015,329	$ 7,039,337
Cost of expenses:
Cost of revenues	2,026,121	1,567,313		4,265,421	3,249,087
Research and development expenses	149,163	186,372		303,829	413,852
Selling, general, and administrative expenses	2,276,284	1,888,449		4,497,113	3,706,983
Total costs and expenses	4,451,568	3,642,134		9,066,363	7,369,922
Loss from operations	(949,726)	(218,353)		(2,051,034)	(330,585)
Interest expense - related party	70,088	40,050		135,800	81,450
Other loss	4,506	5,221		4,506	5,221
Loss before income taxes	(1,024,320)	(263,624)		(2,191,340)	(417,256)
Benefit for income taxes	0	(192,325)		0	(295,390)
Net loss	$ (1,024,320)	$ (71,299)		$ (2,191,340)	$ (121,866)
Net loss per common share - basic	$ (0.13)	$ (0.01)		$ (0.28)	$ (0.02)
Net loss per common share - diluted	$ (0.13)	$ (0.01)		$ (0.28)	$ (0.02)
Weighted average number of common shares outstanding - basic	7,696,091	7,692,913		7,696,091	7,691,534
Weighted average number of common shares outstanding - diluted	7,696,091	7,692,913		7,696,091	7,691,534

[1] Certain April 30, 2017 balances have been restated from previously reported results. Please refer to Note 2 of the Company’s Annual Report on Form 10-K for the year ended October 31, 2017